Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series LLC Ltd : World’s leading Event Organizer

Conference Series LLC Ltd Conferences gaining more Readers and Visitors

Conference Series LLC Ltd Web Metrics at a Glance

  • 3000+ Global Events
  • 25 Million+ Visitors
  • 25000+ unique visitors per conference
  • 70000+ page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts


About World Vaccine Meet 2019

World Vaccine Meet 2019

World Vaccine Meet 2019 proudly invites all the eminent personalities’ world widely to attend “World Conference on vaccine and Immunology” during November 22-23, 2019 at Dubai, UAE. World Vaccine Meet 2019 will focus on the theme “Investigating Entire Advances in the Field of Vaccine and Immunology”.

World Vaccine Meet 2019 aims to gather the most elegant societies and industries along with the renowned and honourable persons form top universities across the globe. On behalf of all the Organizing Committee Members we, invite all the Vaccine & Immunology researchers, industrialists, young scientists as well as student and corporate kings to join and to give a great success. During this conference, the International symposiums, B2B meetings, international workshops will also be organized to discuss the specific topics in the field of Immunology and Vaccine. This world conference also welcomes global exhibitions from corporate sectors to grandstand the on-going progressions in apparatuses and methods. 


This conference will be a valuable and important platform for inspiring international and interdisciplinary exchange at the forefront of Vaccine and Immunology. During the course of 2 days, world-wide eminent speakers will discuss how their research journey has developed in response to contemporary challenges: inspirational and innovative lessons in. The going to specialists and industry accomplices will likewise give an awesome systems administration encounter. The series of talks, poster presentations, workshops, discussions and networking events will keep participants engaged in learning and making new connections at World Vaccine Meet 2019. The Conference will unite academicians, scientific experts, researchers, dermatologist, nutritionists, pathologist, virologist, paediatricians, and technologists from everywhere throughout the world, and we trust that you will accept this open door to go along with us for scholarly trade and visit the city of Dubai.

The Scope

The extent of World Vaccine Meet 2019 spreads both hypothetical, viable, look into zones of Vaccine and Immunology. The point by point territories of enthusiasm for this gathering is recorded in the segment of "Abstract Submission". All the intrigued takes part is welcome to present their edited compositions to affirm their joining. The focused on point of this gathering is to give a chance to the representatives/speakers to meet, cooperate and trade new thoughts on the different subjects under a rooftop.

World Conference on Vaccine and immunology is involved different tracks and sessions intended to offer extensive sessions that address current issues in the field of Vaccine and Immunology:

Target Audience

  • Immunology Researchers
  • Immunology Faculty
  • Directors, CEOs, Presidents and Vice Presidents
  • Medical Colleges
  • Vaccine Developers and Investigators
  • Vaccine &Immunology Associations and Societies
  • Directors, CEOs, Presidents and Vice Presidents
  • Clinical Data Management Companies
  • Business Entrepreneurs
  • Software developing companies
  • Training Institutes
  • Manufacturing Medical Devices Companies
  • Vaccines & Immunization, Scientists

Conference Highlights

  • Vaccine & Immunization
  • Pathology and Immunology
  • Immunological Disorders
  • Human Vaccines-infectious & non- infectious
  • Child immunization and Vaccination
  • Viral Immunology
  • Current research, Production,  Development and future challenges in vaccines
  • DNA & Synthetic Conjugate Vaccines
  • Travel & Edible Vaccines
  • Paediatric Vaccination
  • Neuroendocrine Immunology
  • Vaccine Safety & Efficacy
  • Immunization and pregnancy
  • Psychoneuroimmunology (Animal models of disease)
  • Animal & Plant Derived Vaccines
  • Immunotoxicology
  • Immunopathogenesis
  • Immunoinformatics
  • Stem cell Immunology
  • Clinical and Diagnostic Immunology
  • Geriatric Immunizations
  • Vaccines against Drugs
  • Onco Immunology
  • Allergy, Asthma and Immunology



Highlights of Vaccine and Immunology 2019

Track 1: Vaccine & Immunization

The goal of public health is to prevent disease. It's much easier and more cost-effective to prevent a disease than to treat it. That's exactly what immunizations aim to do. Immunizations, or vaccines as they're also known, safely and effectively use a small amount of a weakened or killed virus or bacteria or bits of lab-made protein that imitate the virus in order to prevent infection by that same virus or bacteria.

Vaccine Types:

  • Inactivated Vaccines
  • Live, Attenuated Vaccine
  • Subunit Vaccines
  • Conjugate Vaccines
  • Toxoid Vaccines  

Two additional types of vaccines being researched:

  • DNA Vaccines
  • Recombinant Vector Vaccines 


Track 2: Pathology and Immunology

Immunopathology is a branch of medicine that deals with immune responses associated with disease. It incorporates the investigation of the pathology of a life form, organ framework, or ailment concerning the insusceptible framework, invulnerability, and resistant reactions. In science, it alludes to the harm caused to a creature by its own resistant reaction, because of a contamination. Two decade of clinical involvement with immunomodulatory medicines for various sclerosis points to unmistakable immunological pathways that drive ailment backslides and movement. Immunopathology could allude to how the outside antigens cause the invulnerable framework to have a reaction or issues that can emerge from a living being's own particular resistant reaction on itself. There are sure issues or blames in the invulnerable framework that can prompt more genuine sickness or malady.

Track 3: Immunological Disorders

Immune system disorders cause abnormally low activity or overactivity of the immune system. In cases of immune system overactivity, the body attacks and damages its own tissues (autoimmune diseases). Immune deficiency diseases decrease the body's ability to fight invaders, causing vulnerability to infections.

  •         Rheumatoid arthritis
  •         Systemic lupus erythematosus
  •         Inflammatory bowel disease
  •         Multiple sclerosis
  •         Type 1 diabetes mellitus
  •         Guillain
  •         Chronic inflammatory demyelinating polyneuropathy
  •         Psoriasis.
  •         Graves' disease
  •         Hashimoto's thyroiditis
  •         Myasthenia gravis
  •         Vasculitis


Track 4: Human Vaccines-infectious & non- infectious

Infectious diseases, including HIV/AIDS, tuberculosis(TB), malaria, poliomyelitis, and some others tropical diseases (NTDs) are rapidly spread out through communication(verbal), water, and wind. It also transmitted by vectors (mosquitoes, flies) and a major issue in developing countries. In the past, infectious diseases had been widely spread-out in developing countries and chronic diseases were found primarily in high-income countries. However, the global pattern of disease burden is shifting. While infectious disease still remains a major problem in many countries, chronic diseases, including such non-communicable conditions as cardiovascular disease, cancer, diabetes, and respiratory disease, are now the major cause of death and disability, not only in developed countries but also worldwide. The greatest total numbers of chronic diseases (Alzheimer, Arthritis, Asthma, Cancer, COPD, Crohn disease, Cystic fibrosis, Diabetes) deaths and illnesses now occur in up-growing countries.

Track 5: Viral Immunology

Viruses are firmly immunogenic and actuate 2 sorts of resistant reactions; humoral and cellular. The collection of specificities of T and B cells are framed by modifications and substantial transformations. T and B cells don't, for the most part, perceive similar epitopes present on a similar infection. B cells see the free unaltered proteins in their local 3-D adaptation though T cells typically observe the Ag in a denatured frame related to MHC atoms. The qualities of the resistant response to a similar infection may vary in various people contingent upon their hereditary constitutions.

Humoral response is in charge of obstructing the infectivity of the infection (balance). Those of the IgM and IgG class are particularly significant for resistance against viral diseases joined by viremia, while those of the IgA class are vital in contaminations procured through a mucosa. (the nose, the digestive tract) interestingly, the cell reaction kills the infection tainted cells communicating viral proteins on their surfaces, for example, the glycoproteins of wrapped infections and some of the time center proteins of these infections.

Track 6: Current research, Production,  Development and future challenges in vaccines

The field bargains on the whole with different sorts of antibodies, their blend, remedial impacts, and clinical improvements. The field completely covers every one of the headways, advancements of antibodies in each field of immunization. Immunizations treating jungle fever, malignancy, and numerous different sicknesses can be altogether considered under this field. The antibody can be characterized as an organic planning that gives dynamic gained invulnerability to a specific illness. 

Track 7: DNA & Synthetic Conjugate Vaccines

Conjugate antibodies, made up of a bacterial polysaccharide antigen cross-connected to a bacterial protein, are among the best immunizations accessible today to avert bacterial diseases, for example, pneumococcal and meningococcal contaminations. Conjugate antibodies against bacterial pathogens with a substantial number of serotypes, for example, Streptococcus pneumoniae, generally cover just a few the current strains. Another recombinant DNA-based assembling innovation has been created to avert genuine bacterial diseases. 

Track 8: Travel & Edible Vaccines

Travel antibodies, additionally called travel inoculations, are shots voyagers can get before visiting certain territories of the world that assistance shields them from genuine diseases. Immunizations work by presenting the body to germs or parts of germs of the sickness it will ensure against. You can't get the ailment from the antibody in light of the fact that the infections or microorganisms are dead or seriously debilitated. The body reacts to the inoculation by making antibodies that will ensure us in the event that we are presented to the illness later on.

Track 9: Pediatric Vaccination and Child immunization

Antibodies that should be regulated to people amid the youth phase of life can be named as Child immunizations. These immunizations are basically in charge of the enlistment of a safe framework and advancement of immunogenic reaction inside the tyke. The sicknesses avoided by the newborn child and youth antibodies are not kidding and even fatal. Measles can spread to the cerebrum, cause mental harm and demise. Mumps can cause lasting deafness. Polio can cause loss of motion. Unfortunately, these illnesses have not vanished. There is no treatment and no solution for maladies like measles, polio, and tetanus. The best way to ensure your youngster is through immunization.

  • Nanopatch
  • Pharmajet
  • Sugar Microneedles
  • Nasal Spray
  • Dry Powder

Track 10: Geriatric Immunizations

The vaccination arrangement is as of now for the most part centered around the youthful (matured beneath 18), to some degree the old (matured over 65) be that as it may, as opposed to youth inoculation programs, grown-up immunization isn't thought to be a normal wellbeing intercession. Vaccination in adults remains an underused public health strategy in the promotion of healthy aging, and adult vaccination rates are still far below the target. Influenza, pneumococcal pneumonia and pneumococcal invasive disease, pertussis and even HZV (because of a high incidence of post-herpetic neuralgia among the elderly) have been featured as the most imperative illnesses for which is vital to care for vaccination methodologies because of their weight identified with passings or inabilities. Investing € 1 in adult immunization can generate over € 4 of future economic revenue for the government.

Track 11: Vaccines against Drugs

Drug addiction is a difficult issue around the world. One treatment being explored is immunizations against medications of mishandling. The antibodies inspired against the medication can take up the medication and keep it from achieving the reward focuses on the mind. Scarcely any such immunizations have entered clinical preliminaries, however, look into is going on apace. Numerous examinations are exceptionally encouraging and more clinical preliminaries ought to turn out sooner rather than later.

Track 12: Allergy, Asthma, Autism & Immunology

Allergies, also known as allergic diseases, are a number of conditions caused by of the immune system to something in the environment that usually causes little problem in most people. A damaging immune response by the body to a substance, especially a particular food, pollen, fur, or dust, to which it has become hypersensitive. Common allergens include pollen and food. Symptoms of food allergy include abdominal pain, bloating, vomiting and swelling of the skin during hives. Effective management of allergic diseases relies on the ability to make an accurate diagnosis. 

Track 13: OncoImmunology

Although tumor immunologists have been convincing themselves over the last decades that cancer can be conceived as an immunological problem—a few cells expressing novel antigens proliferate in the uncontrolled fashion, in spite of the immune system’s attempts to eliminate them—they have been standing alone. Most basic cancer researchers, drug developers and clinical oncologists have been considering neoplasia as a purely cell-autonomous genetic disease and have been ignoring or even neglecting the impact of immunology on tumorigenesis, for multiple reasons.

Track 14: Immunoinformatics

Immunoinformatics (in some cases alluded to as computational immunology) is a sub-part of bioinformatics that spotlights on the utilization of information administration and computational apparatuses to enhance immunological research. The extent of immunoinformatics covers a wide assortment of a domain, from the genomic and proteomic investigation of the resistant framework to sub-atomic and life form level demonstrating, placing it in close ties with genome informatics.

  • improving the development of biological therapeutics
  • developing and improving analysis and data management solutions for immunogenetics
  • developing and improving allergen and other immunological databases
  • creating better mathematical and computer models of the immune system
  • predicting protein allergenicity for the screening of novel foods before wide-scale release and use
  • the design and development of peptide-based immuno-therapeutic drugs and vaccines

Track 15: Stem cell Immunogenicity

Foreseeing the immunogenicity of a stem cell therapy is fundamental to empower sheltered and powerful procedures for anticipating invulnerable assault to be outlined. The immunogenicity of autologous prompted PSCs (iPSCs) changes between clones. Undifferentiated immature microorganisms are more immunogenic than their separated offspring. Distinctive kinds of tissue separated from a similar foundational microorganism can show diverse levels of immunogenicity.Stem cells jumbled with the patient for real histocompatibility complex (MHC) as well as minor histocompatibility (miH) antigens are immunogenic. miH antigen contrasts can be acquainted by the advancements utilized with creating pluripotent immature microorganisms (PSC, for example, confused mitochondrial antigens present in the enucleated oocytes used to deliver atomic exchange embryonic foundational microorganisms (NT-ESC).

Track 16: Clinical and Diagnostic Immunology

Diagnostic immunology is the investigation of ailments that are caused by the disarranges of a resistant framework. It manages investigations of maladies caused because of scatters of invulnerable framework issue i.e., irregular development of any cell tissues of the framework, hypersensitivities, for example, in asthma and different sensitivities, safe framework disappointment. It additionally incorporates the ailments of different frameworks, where safe responses assume a fundamental part in the clinical viewpoints and pathology. It has been comprehensively partitioned into two classes: Immunodeficiency is a classification in which there is insufficient reaction achieved by the invulnerable framework, though on account of autoimmunity the host body itself assaults its own particular insusceptible framework.

Track 17: Immunotoxicology

Immunotoxicology is the investigation of the undesired tweak of the safe framework by extraneous elements. Toxicological evaluations have exhibited that the invulnerable framework is an objective after introduction to an assorted gathering of xenobiotics including bright radiation, concoction poisons, therapeutics, and recreational medications. Nonetheless, since xenobiotics may have consequences for in excess of one part of invulnerable capacity, immunotoxicity information ought to be assessed independently for confirmation of concealment, incitement, extreme touchiness, and autoimmunity.

Track 18: Animal & Plant-Derived Vaccines

It has been around a long time since the principal plant building innovation was set up. Despite the fact that the idea of plant-based pharmaceuticals or vaccine spurs us to create practicable business items utilizing plant designing, there are a few challenges in achieving the last objective: to fabricate an endorsed item. At present, the main plant-made immunization affirmed by the United States Department of Agriculture is a Newcastle malady vaccine for poultry that is created in suspension-refined tobacco cells

Track 19: Neuroendocrine & Psychoneuro Immunology (Animal models of disease) 

The safe capacity of neuroendocrine control is imperative for the presence amid stress or contamination and in addition to direct safe reactions in incendiary ailments. Glucocorticoids go about as principle effector end purpose of the neuroendocrine framework.

Psychoneuroimmunology, which researches the bidirectional correspondence between the focal sensory system and the immune system, has been extraordinarily cutting-edge by the utilization of creature models. The target of this theme is to portray creature models of illness that can or may be used to illustrate neural-resistant cooperations that modify pathogenesis. Creature thinks about in psychoneuroimmunology feature the many-sided quality of the cooperations among conduct, the cerebrum, the insusceptible framework, and pathogen. The hereditary foundation of the creature (both as far as focal apprehensive and safe framework reactions), its past history, the nature of stressor, the nature of pathogen and the kind of insusceptible reaction produced are a portion of the communicating factors that decide the extent and course of stress-instigated changes in malady result.

  • Clinical Trial
  • Clinical Research
  • Internal Medicine
  • Clinical Practice
  • Therapeutic Approach
  • Experimental allergic encephalomyelitis (EAE)
  • Immunomodulation
  • Immunosuppression

 Track 20: Immunization and pregnancy

Immunizations help secure a mother and her infant against genuine sicknesses. A mother presumably realizes that when she is pregnant, she shares everything with her infant. That implies when she get vaccines, she isn't simply ensuring herself—she is giving her child some early insurance as well. CDC suggests a mother get whooping cough and flu vaccine during each pregnancy to help protect herself and her baby.

  • Vaccines specifically recommended during pregnancy and postpartum;
  • Vaccines recommended during pregnancy and postpartum based on risk factors and special circumstances;
  • Vaccines currently under research and development for licensure for maternal-fetal immunization;
  • Barriers to maternal immunization and available patient and provider resources.

Track 21: Vaccine Safety & Efficacy

For as far back as two centuries, vaccines have given sheltered and successful methods for keeping various irresistible sicknesses. In spite of the fact that the security of a few immunizations has been addressed later, the at presently accessible antibodies are in excess of a millionfold more secure than the sicknesses they are intended to forestall. Vaccines are right now accessible for just a set number of viral and bacterial ailments. Later on, it is foreseen that sheltered and compelling immunizations will be produced against various other viral and bacterial contaminations and contagious and protozoan maladies. The security and adequacy of immunizations are under consistent examination. Since immunizations are intended to be given routinely amid well-tyke mind visits, they should be uncommonly sheltered. Wellbeing testing starts when another antibody is examined, proceeds until the point that it is authorized, and is checked uncertainly after licensure. 

The American Academy of Pediatrics (AAP) works intimately with the Centers for Disease Control and Prevention (CDC) to make proposals on using of vaccines.

Market Analysis Report

Market Analysis Report of Vaccine and Immunology, 2019

Why Dubai, UAE

Inferable from cutting edge and inventive ability, assets and foundation, Dubai today has turned into a world-class goal that is a mixture of societies and dynamic goal contributions. Immovably situated as the fourth most visited, and a standout amongst the most cosmopolitan urban communities on the planet, Dubai is genuinely where the east meets west. With its change from a little exchanging port to a flourishing city in a strikingly brief time, Dubai has turned into a thriving example of overcoming adversity. The United Arab Emirates' most crowded city is a mix of striking and aggressive engineering, sunburned hills, and a purplish blue coastline. It is anything but difficult to get to the city, as Dubai is all around served by world-class air terminals, a few ports, and a decision of parkways and transport courses. The key geographic area accompanies a pleasant, direct atmosphere that guarantees blue skies and shoreline climate notwithstanding amid winter months. The city's flourishing business network, its shining nightlife and an interesting society are altogether viewpoints that add to the worldwide interest of Dubai. With a culture surely understood for giving careful consideration to detail, your occasion will be provided food for with care and polished skill.

A thrilling mix of desert city, shopping destination, golfing mecca, and sky scraping business centre, Dubai is a prime city for meetings and events in the United Arab Emirates.

  • Burj Khalifa
  • Dubai Mall
  • Dubai Museum
  • Bastakia (Old Dubai)
  • Sheikh Saeed Al-Maktoum House
  • Dubai Creek
  • Jumeirah Mosque
  • Deira
  • Sheikh Zayed Road
  • Heritage and Diving Village
  • Dubai Aquarium
  • Burj al-Arab
  • Jumeirah Beach
  • Mall of the Emirates
  • IMG Worlds of Adventure
  • Dubai Opera
  • Kite Beach
  • Alserkal Art District
  • Dubai Parks and Resorts
  • Aquaventure Waterpark

If you want easy access to Dubai's top tourist attractions, the best place to stay is Downtown Dubai. Prime attractions close-by incorporates the point of interest Burj Khalifa, the world's tallest building; Dubai Mall; and the Dubai Fountain. You'll likewise discover a lot of shops, eateries, and workmanship displays in this dynamic region. In case you're looking for some sun, sand, and ocean, Jumeirah Beach lies around 15 minutes via four-wheeler from Burj Khalifa and is additionally a famous base for visitors.

Middle East Human Vaccines Market 2018 | Highlights and Trends Estimates High Demand | with 11.8% of CAGR | Analysis and Forecast to 2022

The new report will catch up on helping organizations to line up with the quickly changing business sector slants and extend their pieces of the pie in undiscovered portions. It will likewise give a profound comprehension of the various components affecting the development of the market over the globe.

The refreshed research write about the worldwide human antibody showcase is a basic piece of the World Vaccine Meet 2019 portfolio. It covers an extensive variety of statistical surveying provides details regarding the immunizations showcase, featuring the present market elements for the business. A portion of the subjects secured incorporate cephalosporin drugs, flu immunization, cholera antibody, and human blend immunization. The report has been intended to give a superior perspective of the market alongside the traps prone to be experienced. The report gives a positive attestation of the probable dangerous CAGR development, which in our investigation is required to convey the most noteworthy conceivable rates of profitability.

Companies Associated with Vaccines Research and Production

  • Atara
  • CareDx
  • Activartis         
  • AFFiRiS          
  • Hookipa Biotech Vienna,
  • s-TARget Therapeutics
  • Themis Bioscience       
  • Valneva
  • Biotherapeutics
  • Benitec Limited
  • InterMune
  • Biotron Limited
  • BioDiem
  • Antisense Therapeutics Limited      
  • GlaxoSmithKline USA Pty Ltd
  • Bionomics
  • USAn Pharmaceutical Industries (API)  
  • BioPharmica Limited

The global human vaccines market has been segmented as presented below:

Global Human Vaccines Market: Vaccine

  • Conjugate
  • Recombinant
  • Inactivated
  • Combination
  • Attenuated

Global Human Vaccines Market: Product

  • Pneumococcal
  • Influenza
  • Hepatitis
  • HPV
  • Meningococcal
  • Rotavirus
  • Measles and Mumps
  • Typhoid
  • Combination

Global Human Vaccines Market: Age Group

  • Paediatrics
  • Adolescents
  • Adults
  • Geriatrics

Global Human Vaccines Market: Distribution Channel

  • Hospital Pharmacies
  • Drugstores

Global Human Vaccines Market: Region

North America

  • U.S.
  • Canada
  • Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Spain
  • Rest of Europe

Asia Pacific (APAC)

  • Japan
  • China
  • Rest of APAC
  • Latin America (LATAM)
  • Brazil
  • Mexico
  • Rest of LATAM

Middle East and Africa (MEA)

  • GCC
  • South Africa
  • Rest of MEA

Market Scenario:

The Middle East and Africa are slow pokes with regards to vaccination scope. As per the World Health Organization (WHO), out of the aggregate number of kids overall who did not get the required three measurements of diphtheria-lockjaw pertussis immunizations, over 40% were from sub-Saharan Africa. Different countries with substantial unvaccinated populace incorporate Nigeria, Iraq, Chad, Niger, Angola, Somalia, and Sudan. UNICEF appraises that the Central African Republic, Equatorial Guinea, Somalia, South Sudan, Syrian Arab Republic, and Ukraine had under 50%coverage of the third dosage of diphtheria, lockjaw, and pertussis (DTP) antibody. The greater part of the unvaccinated youngsters live in the Democratic Republic of Congo, Ethiopia, India, Indonesia, Iraq, Nigeria, Pakistan, Philippines, Uganda, and South Africa.

The low productivity in antibody fabricating has decreased motivating forces for creating immunizations for illnesses of the creating scene, for example, tuberculosis and intestinal sickness.

The market's patterns incorporate solid research pipeline under which various novel immunizations are being produced, for example, rubella vaccine, Ebola vaccine and so forth. DNA recombinant innovation is additionally a typical innovation utilized in the improvement of novel acting immunizations.


The Middle East and Africa Human Vaccines Market have been portioned based on innovation which involves lessened, inactivated, toxoid, conjugate and subunit, recombinant DNA. Based on ailment sign; the market is fragmented into pneumococcal, flu, hepatitis, rotavirus, DTP, polio and others. Based on the sort, the market is divided into prophylactic and restorative. Based on synthesis, the market is again fragmented into a mono vaccine and combination vaccines. The course of organization portions the market into oral, injectable and other. Also based on the end client; the market is sectioned into youngsters and grown-ups.

Regional Analysis:

Contingent upon geographic locale, human antibody advertise is sectioned into a few nations: UAE is the biggest market for human immunizations in the whole Middle East and Africa human immunizations showcase nearly taken after by Egypt. Whatever remains of Africa's market particularly Sub Saharan areas are anyway the quickest developing business sector with an enormous unmet therapeutic need.

 Study Objectives Middle East and Africa Human Vaccines Market:

  • To give detail investigation of the market structure alongside the figure for the following 6 years in different sections and sub-portions of the Middle East and Africa human immunizations advertise.
  • To give bits of knowledge into factors influencing the market development.
  • To break down the market in light of different examinations which incorporate value investigation, inventory network examination, Porters Five Force investigation and so on.
  • To give past and assessed future income of the market's portions and sub-sections as for the Middle East and Africa human antibodies advertise.
  • To give nation level examination of the market as for the present market size and future development prospect.
  • To provide country level analysis of the market for segments which includes by technology, by disease indication, by type, by composition, by end user, by route of administration and other sub segments.
  • To give a review of key players and their key profiling in the market, completely investigating their centre abilities, and drawing a focused scene of the market.
  • To track and break down focused improvements, for example, joint endeavours, vital partnerships, mergers and acquisitions, new item advancements alongside research and advancements internationally.

Veterinary Vaccines Market | Middle East Industry Analysis & Opportunity Assessment, 2016 – 2026

  • Lessened live vaccines are relied upon to rise as the predominant antibody compose portion over the gauge time frame.
  • Rising frequency of foodborne and zoonotic infections in MEA nations liable to fuel the interest for weakened live antibodies.
  • Lessened live antibodies are required to see expanded request all through the gauge time   frame in Jordan.


The MEA district represents an immense domesticated animal’s populace; be that as it may, it is to a great extent reliant on imports for the supply of sufficient veterinary antibodies. Just six nations have the office to deliver antibodies locally. These incorporate Egypt, Jordan, Saudi Arabia, Sudan, Syria and Turkey.

Just four nations take after the worldwide standards of OIE in spite of the fact that the OIE has not yet settled authority universal guidelines in this regard.

What makes our report unique?

  • A broad research examines on the Global Human Vaccines market, and its whole biological system, depicts the market patterns, drivers, restrictions and chances of the Human Vaccines advertise.
  • We give you the longest conceivable market division in view of kind of items, strategies and topography and portray the piece of the pie district shrewd.
  • The report gives a winged animal eye see on the aggressive scene which incorporates mergers and acquisitions, joint efforts, advertise systems, and new item dispatches.

  List of Vaccine & Immunology Societies



Past Conference Reports


Vaccines Summit 2018

29th International Conference on Vaccines and Immunization (Vaccines Summit 2018) was organized by ME Conference during March 19-20, 2018 in London, UK,

Generous response was received from the Editorial Board Members of ME Conference Journals as well as from eminent scientists, talented researchers, and young student community. Researchers and students who attended from different parts of the world made the conference one of the most successful and productive events in 2018. The two-day program witnessed thought to provoke keynote and plenary presentations from experts in the field of Vaccines and Immunization, highlighting the theme “Highlights of the latest technologies and innovations in Vaccines and Immunization “

The meeting was carried out through various sessions, in which the discussions were held on the following major scientific tracks:

  • Bacterial and Viral Vaccines
  • Vaccines Against infectious diseases
  • Cancer Vaccines
  • DNA, Protein and Toxoid Vaccines
  • Combination and Conjugate Vaccines
  • Travel and Edible vaccines
  • Malaria and TB Vaccines
  • Hepatitis, HIV and STD Vaccines
  • Paediatric Vaccination
  • Vaccines for Immune-mediated Diseases
  • Vaccination for Emerging and Re-emerging diseases
  • Vaccine production and delivery technologies
  • Vaccine Safety and Efficacy
  • Vaccines Industry & Manufacturing
  • Geriatric Immunization
  • Vaccines for unconventional diseases
  • Animal and Plant Derived Vaccines
  • Vaccines for Pregnant women and Neonates
  • Animal Models and Clinical Trials
  • Cellular Immunology and Latest Innovations
  • Clinical Immunology & Cancer Immunotherapy
  • Molecular and Structural Immunology
  • Antibodies : Engineering and Therapeutics

The highlights of the meeting were the eponymic keynote lectures from

Ronald Ellis, Chief Technology Officer FutuRx Ltd., Israel

Ivana Haluskova Balter, French society of immunology, France

Eli Boritz, Chief, Virus Persistence and Dynamics Section (VPDS)USA

Natalia Romanenkova, Pasteur Institute in St. Petersburg, Russia

Pramod Jog, Member of GAVI, India

Imran Saleem, Liverpool John Moores University, UK

Francisco Diaz-Mitoma, Bowhead Health, University of Alberta, Canada

Vaccines Summit 2018 played an important role in promoting multidisciplinary interactions between Science and Medicine to enhance research in Vaccines and Immunization. The program covered current and emerging research innovations in the field of Vaccines and Immunology.

We are obliged to the various delegates from companies and institutes who actively took part in the discussions. We sincerely thank the Organizing Committee Members and Editorial board of Vaccines Summit 2018 for their gracious presence and continuous support throughout the proceedings of this event. With the valuable feedback and generous response received from the participants of the event, ME Conferences would like to announce the commencement of “World Conference on Vaccine and Immunology" on November 22-23 2019, Dubai, UAE.


  • Harvard University
  • Stanford University
  • Yale University
  • Columbia University
  • University of California--Los Angeles
  • Duke University
  • University of Pennsylvania
  • University of California
  • University of Pittsburgh
  • University of Michigan
  • Johns Hopkins University
  • New York University
  • Massachusetts Institute of Technology
  • University of Minnesota--Twin Cities
  • University of North Carolina--Chapel Hill
  • Washington University in St. Louis
  • University of California--Berkeley
  • University of Washington
  • University of Chicago
  • Cornell University
  • Vanderbilt University
  • University of California--San Francisco
  • University of California--Davis
  • Northwestern University
  • Princeton University
  • Emory University
  • University of Wisconsin—Madison
  • Ohio State University--Columbus
  • Boston University
  • Pennsylvania State University--University Park
  • University of Texas--Austin
  • University of Virginia
  • University of Rochester
  • University of California--Irvine
  • Brown University
  • University of Southern California
  • Michigan State University
  • University of Iowa
  • University of Maryland--College Park
  • Arizona State University--Tempe
  • Stony Brook University--SUNY
  • Indiana University--Bloomington
  • Mount Sinai School of Medicine
  • University of Miami
  • Florida State University
  • University of Arizona
  • University of Colorado--Boulder
  • Carnegie Mellon University
  • University of Illinois--Chicago
  • Dartmouth College
  • University of Missouri
  • University of Oregon
  • University of Florida
  • Purdue University
  • University of California
  • University of Connecticut
  • University of Texas Southwestern Medical Center--Dallas
  • The State University of New Jersey
  • Texas A&M University--College Station
  • Yeshiva University
  • Baylor College of Medicine
  • University of Maryland--Baltimore
  • University of Utah
  • Tufts University
  • University of Cincinnati
  • University of South Florida
  • University of New Mexico
  • University of Kansas
  • Temple University
  • Case Western Reserve University
  • University of California--Riverside
  • University of Georgia
  • University of Notre Dame
  • University of Kentucky
  • Medical University of South Carolina


  • King's College London
  • University College London
  • University of Oxford
  • University of Cambridge
  • Karolinska Institute
  • University of Amsterdam
  • VU University Amsterdam
  • Catholic University of Leuven
  • University of Groningen
  • University of Munich
  • Maastricht University
  • Radboud University Nijmegen
  • Aarhus University
  • Ghent University
  • University of Zurich
  • University of Barcelona
  • Humboldt-Universität zu Berlin
  • Technical University of Dresden
  • Cardiff University
  • University of Copenhagen
  • Heidelberg University
  • University of Manchester
  • University of Edinburgh
  • Freie Universität Berlin
  • Leiden University
  • University of Bristol
  • University of Basel
  • Erasmus University Rotterdam
  • University of Geneva
  • Tilburg University
  • University of Sussex
  • Birkbeck University London
  • University of Oslo
  • Eberhard Karls University, Tübingen
  • Imperial College London
  • University of Exeter
  • Paris Descartes University-Paris V
  • University of Bern
  • University of York
  • University of Birmingham
  • University of Southampton
  • University of Bonn
  • Newcastle University
  • University of Cologne
  • Charite - Medical University of Berlin
  • University of Warwick
  • Sapienza University of Rome
  • University of Helsinki
  • Autonomous University of Barcelona
  • University of Göttingen
  • University of Nottingham
  • University of Glasgow
  • University of Würzburg
  • University of Padua
  • University of Leipzig
  • University Catholique of Louvain
  • Technical University of Munich
  • Philipps University of Marburg
  • University of Konstanz
  • University of Leicester
  • University of Freiburg
  • Trinity College Dublin
  • University of Gothenburg
  • University of Kent
  • United Kingdom Canterbury, Kent
  • University of Milan - Bicocca
  • Uppsala University
  • University of Turku
  • University of Hamburg
  • London School of Economics and Political Science
  • University of Bergen
  • University of Leeds
  • University of Sheffield
  • Medical University of Vienna
  • University of Bologna
  • University of Münster
  • Friedrich Schiller University of Jena
  • Linköping University
  • Pierre and Marie Curie University
  • Lund University
  • Durham University
  • University of Lausanne
  • Johann Wolfgang Goethe University Frankfurt am Main
  • Stockholm University
  • University of Valencia


  • Gulf Medical University
  • United Arab Emirates University
  • University of Sharjah
  • King Saud University
  • Cairo University
  • King Abdulaziz University
  • American University of Beirut
  • Qena Faculty of Medicine
  • Kasr El-Aini Faculty of Medicine, Cairo University
  • Ain Shams University Faculty of Medicine
  • Alexandria Faculty of Medicine
  • Mansoura Faculty of Medicine
  • Mansoura Manchester Medical Programme
  • Faculty of Medicine Zagazig University
  • Benha Faculty of Medicine, Benha University
  • Fayoum Faculty of Medicine
  • Assiut Faculty of Medicine
  • Suez Canal Faculty of Medicine
  • Minia Medical School
  • Monofia Faculty of Medicine
  • Sohag Faculty of Medicine
  • Tanta Faculty of Medicine
  • Alfaisal University
  • Ain Shams University
  • Mansoura University
  • Université de Tunis El Manar
  • King Saud bin Abdulaziz University for Health Sciences
  • United Arab Emirates University
  • Kuwait University
  • Assiut University
  • Université de Monastir
  • Université de Sfax
  • Sultan Qaboos University
  • Jordan University of Science & Technology
  • Minia University
  • King Khalid University
  • University of Tanta
  • Al Azhar University
  • Zagazig University
  • University of Balamand
  • University of Jordan
  • Menoufia University
  • Université du Sousse
  • University of Khartoum
  • Université de la Manouba
  • Université Saint Joseph de Beyrouth
  • University of Dammam
  • King Faisal University
  • Université Libanaise
  • Qassim University
  • Beni-Suef University
  • Université Mohammed V Agdal
  • Sohag University
  • Helwan University


  • University of Hong Kong
  • Tel Aviv University
  • Hebrew University of Jerusalem
  • National University of Singapore
  • Chinese University Hong Kong
  • Peking University
  • Seoul National University
  • Beijing Normal University
  • Nanyang Technological University
  • National University of Singapore
  • Tsinghua University
  • Peking University
  • Nanyang Technological University
  • Chinese University of Hongkong
  • University of Tokyo
  • Seoul National University
  • Kyoto University
  • Sungkyunkwan University
  • Fudan University
  • Zheijiang University
  • Shanghai Jiao Tong University
  • Yonsei University
  • Korea University
  • Tel Aviv University
  • National Taiwan University
  • Hebrew University of Jerusalem
  • Osaka University
  • Tohoku University
  • Koc University
  • Sabancı University
  • Nagoya University
  • Sun Yat-sen University
  • University of Malaya
  • University of Macau
  • Kyushu University
  • Chung-Ang University
  • Bar-Ilan University
  • Qatar University
  • Bilkent University
  • Hokkaido University
  • Hong Kong Baptist University
  • National Cheng Kung University
  • University of Tsukuba
  • Tianjin University
  • Ewha Womans University
  • Bogazici University
  • United Arab Emirates University
  • Soochow University
  • National Taiwan Normal University
  • American University of Beirut
  • Central China Normal University
  • Quaid-i-azam University
  • Xiamen University
  • Indian Institute of Technology Kanpur
  • Renmin University of China

To Collaborate Scientific Professionals around the World

Conference Date November 22-23, 2019 |

For Sponsors & Exhibitors

Speaker Opportunity

Supported By

Journal of Clinical & Cellular Immunology Immunology: Current Research Journal of Vaccines & Vaccination

All accepted abstracts will be published in respective Conference Series LLC LTD International Journals.

Abstracts will be provided with Digital Object Identifier by